M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bio
PR Newswire —
LONDON, Jan. 9, 2026 /PRNewswire/ -- M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming technology. The investment of patient capital into a...